Plus, foods high in saturated fats can worsen nausea you may experience while taking Zepbound
Clinical trials show semaglutide users experience sustained weight loss averaging 10-15% of body weight over 68 weeks, with effects persisting as long as therapy continues
Subgroup analysis Semaglutide significantly reduced SBP levels (WMD: 3.01, 95% CI: 4.03 to 2.00) compared with placebo, and its effect was also superior to other AHAs (WMD: 1.85, 95% CI: 2.93 to 0.77) (Fig
The Microdose GLP-1 Protocol ($129/month flat) offers another pathway for patients who experience mood sensitivity at standard doses, using lower starting concentrations to minimize neurological side effects while still achieving meaningful weight reduction
Its sometimes added to GLP-1 therapies to help reduce fatigue
The ESSENCE trial showed significant improvement in liver scarring with no worsening of steatohepatitis, offering new hope for patients